Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04527575
Recruitment Status : Active, not recruiting
First Posted : August 26, 2020
Last Update Posted : February 23, 2021
Sponsor:
Information provided by (Responsible Party):
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : May 2021